172 related articles for article (PubMed ID: 20944653)
1. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process.
Schmitt J; Langan S; Stamm T; Williams HC;
J Invest Dermatol; 2011 Mar; 131(3):623-30. PubMed ID: 20944653
[TBL] [Abstract][Full Text] [Related]
2. TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
Gerbens LAA; Apfelbacher CJ; Irvine AD; Barbarot S; de Booij RJ; Boyce AE; Deleuran M; Eichenfield LF; Hof MH; Middelkamp-Hup MA; Roberts A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Williamson PR; Flohr C; Spuls PI;
Br J Dermatol; 2019 Apr; 180(4):790-801. PubMed ID: 29761486
[TBL] [Abstract][Full Text] [Related]
3. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
[TBL] [Abstract][Full Text] [Related]
4. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
[TBL] [Abstract][Full Text] [Related]
5. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
Schmitt J; Spuls P; Boers M; Thomas K; Chalmers J; Roekevisch E; Schram M; Allsopp R; Aoki V; Apfelbacher C; Bruijnzeel-Koomen C; Bruin-Weller M; Charman C; Cohen A; Dohil M; Flohr C; Furue M; Gieler U; Hooft L; Humphreys R; Ishii HA; Katayama I; Kouwenhoven W; Langan S; Lewis-Jones S; Merhand S; Murota H; Murrell DF; Nankervis H; Ohya Y; Oranje A; Otsuka H; Paul C; Rosenbluth Y; Saeki H; Schuttelaar ML; Stalder JF; Svensson A; Takaoka R; Wahlgren CF; Weidinger S; Wollenberg A; Williams H
Allergy; 2012 Sep; 67(9):1111-7. PubMed ID: 22844983
[TBL] [Abstract][Full Text] [Related]
6. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany.
Schmitt J; Williams H;
Br J Dermatol; 2010 Dec; 163(6):1166-8. PubMed ID: 21137114
[TBL] [Abstract][Full Text] [Related]
7. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
[TBL] [Abstract][Full Text] [Related]
8. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
[TBL] [Abstract][Full Text] [Related]
9. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.
Chalmers J; Deckert S; Schmitt J;
Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):227-33. PubMed ID: 26153875
[TBL] [Abstract][Full Text] [Related]
10. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
11. The HOME Core outcome set for clinical trials of atopic dermatitis.
Williams HC; Schmitt J; Thomas KS; Spuls PI; Simpson EL; Apfelbacher CJ; Chalmers JR; Furue M; Katoh N; Gerbens LAA; Leshem YA; Howells L; Singh JA; Boers M;
J Allergy Clin Immunol; 2022 Jun; 149(6):1899-1911. PubMed ID: 35351441
[TBL] [Abstract][Full Text] [Related]
12. [Health services research the example of atopic dermatitis].
Schmitt J
Hautarzt; 2011 Mar; 62(3):178-88. PubMed ID: 21340649
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.
Jacobson ME; Thomas KS; Apfelbacher CJ; Leshem YA; Williams HC; Gerbens LAA; Spuls PI; Schmitt J; Howells L; Katoh N; Simpson EL;
Arch Dermatol Res; 2023 Nov; 315(9):2617-2622. PubMed ID: 37432466
[TBL] [Abstract][Full Text] [Related]
14. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
Spuls PI; Gerbens LAA; Simpson E; Apfelbacher CJ; Chalmers JR; Thomas KS; Prinsen CAC; von Kobyletzki LB; Singh JA; Williams HC; Schmitt J;
Br J Dermatol; 2017 Apr; 176(4):979-984. PubMed ID: 27858989
[TBL] [Abstract][Full Text] [Related]
15. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
[TBL] [Abstract][Full Text] [Related]
16. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Vermeulen FM; Gerbens LAA; Bosma AL; Apfelbacher CJ; Irvine AD; Arents BWM; Barbarot S; Deleuran M; Eichenfield LF; Manca A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Middelkamp-Hup MA; Spuls PI; Flohr C;
Br J Dermatol; 2019 Sep; 181(3):492-504. PubMed ID: 30719709
[TBL] [Abstract][Full Text] [Related]
17. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
Simpson RC; Kirtschig G; Selk A; von Seitzberg S; Vittrup G; Bissonnette I; Kottner J; Lanthier J; Stanton C; Foster D; Promm M; Augenti A; Lauretti S; Thomas KS;
Br J Dermatol; 2023 Apr; 188(5):628-635. PubMed ID: 36702803
[TBL] [Abstract][Full Text] [Related]
18. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
[TBL] [Abstract][Full Text] [Related]
19. Protocol for the development of a core domain set for hand eczema trials.
Rönsch H; Apfelbacher C; Brans R; Ofenloch R; Schuttelaar MLA; Weisshaar E; Bauer A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2871-2876. PubMed ID: 32274874
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]